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Abstract 3-Aminobenzamide, a known inhibitor of poly-(ADP-
ribose)-polymerase has been found in the cell line U-937 to
inhibit protein kinase C at the same concentration as poly-(ADP-
ribose)-polymerase. 3-Aminobenzamide was not able, however,
to inhibit the isolated enzyme. An indirect mechanism of protein
kinase C inhibition is proposed.
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1. Introduction
Apoptosis is a highly regulated process of cell death. Cells
undergoing apoptosis show characteristic morphological
changes including plasma and nuclear membrane blebbing
as well as chromatin condensation and fragmentation. These
morphological changes are usually accompanied by biochem-
ical changes such as the elevation of cytoplasmic Ca2 and
internucleosomal DNA fragmentation [1]. These changes dis-
tinguish apoptosis from necrotic cell death. In recent years,
the role of poly-(ADP-ribosyl)ation in the cell death process
has been discussed. Poly-(ADP-ribose)-polymerase (PARP) is
a nuclear enzyme that utilizes NAD as substrate to add poly-
(ADP-ribose) chains to several chromatin proteins, and that
can be activated as result of apoptosis-induced DNA frag-
mentation [2]. Several inhibitors of PARP have been de-
scribed, which are used as tools in investigating the role that
the enzyme plays in cell death. Among them, 3-aminobenza-
mide (3-AB) is the most frequently employed since it is sup-
posedly non-toxic and highly speci¢c [3]. Many reports have
shown that 3-AB is capable, in a variety of experimental sys-
tems, of preventing cell death and apoptosis [4^6].
Conversely, activators of protein kinase C (PKC) have been
shown to stimulate apoptosis [7^9], whereas agents that down-
regulate or inhibit this kinase can abrogate apoptosis in sev-
eral model systems [10^12]. Most of the evidence supporting a
role for PKC in apoptosis has been obtained from studies
with phorbol esters, a class of tumor promoters that bind to
the diacylglycerol-binding site on the enzyme and promote its
activation. The involvement of PKC in the apoptotic process
is also con¢rmed by the fact that H2O2, a reactive oxygen
intermediate, can induce apoptosis as well as PKC activation
[13^19]. In this work we analyzed the e¡ect of the classical
PARP inhibitor 3-AB on PMA- and H2O2-induced protein
kinase C activity, using both a cellular system and the isolated
enzyme.
The results show that in the cellular system 3-AB inhibits
protein kinase C activity in a dose-dependent manner. The
protein kinase C inhibition appears to occur via an indirect
mechanism since no inhibition by 3-AB takes place with the
isolated recombinant enzyme.
2. Materials and methods
2.1. Materials
Puri¢ed PKCK was from UBI (New York). The peptide fragment
of myelin basic protein (MBP 4^14) was obtained from Bachem Fein-
chemikalien AG (Duºbendorf, Switzerland). [Q-32P]ATP (10 mCi/ml)
was from Amersham International. All other chemicals used were of
the purest commercially available grade.
2.2. Cell line and cell culture
U-937 cells were cultured in suspension in RPMI 1640 medium
(Gibco, NY, USA) supplemented with 10% fetal bovine serum, pen-
icillin (50 units/ml), and streptomycin (50 Wg/ml) (Sera-Lab, Ltd.,
UK), at 37‡C in T-75 tissue culture £asks (Corning, NY, USA) gassed
with an atmosphere of 95% air-5% CO2. Stock solutions of hydrogen
peroxide were freshly prepared in double-distilled water. 3-AB was
dissolved directly in the culture medium. PMA was dissolved in
DMSO. Because the cytotoxicity of hydrogen peroxide toward cul-
tured cells is dependent on cell density [20], a constant density of
2.5U105 cells/ml dish was used at the treatment stage.
2.3. Puri¢ed PKC activity
PKCK activity in vitro was performed as follows. After preincuba-
tion with 3-AB at 30‡C for 20 min, samples were incubated for 10 min
at 30‡C in 40 Wl activation bu¡er, containing 10 mM MOPS, pH 7.2,
0.5 mM DTT, 100 WM MBP4ÿ14, 0.25 mM ATP, 20 mM MgCl2, 5 Wg
phosphatidylserine, 5 Wg diacylglyceride and 5 WCi [Q-32P]ATP. Reac-
tion was stopped with 20 Wl 25% TCA. Fifty Wl aliquots were spotted
onto 3U3 cm P81 Whatman ¢lter, washed twice with 0.75% phos-
phoric acid, once with acetone. Radioactivity was counted in a liquid
scintillation analyzer.
2.4. PKC activity in permeabilized cells
U-937 cells were subjected to di¡erent treatments as indicated in the
¢gure legends. Aliquots of cells were resuspended in a reaction bu¡er
containing 5.2 mM MgCl2, 94 mM KCl, 12.5 mM HEPES pH 7.4,
12.5 mM EGTA, 8.2 mM CaCl2, and assays were started by adding
[Q-32P]ATP (9 cpm/pmol, ¢nal concentration 250 WM), peptide sub-
strate (¢nal concentration 70 WM), and streptolysin-O (0.3 IU). Sam-
ples were incubated at 37‡C for 10 min, quenched and analyzed as
described previously [21].
3. Results and discussion
The experiments shown in Fig. 1 were aimed to establish if
the protection against apoptosis by 3-AB could be speci¢cally
referred to the inhibition of PARP or if protein kinase C, also
involved in apoptosis, was a¡ected as well. PKC, measured in
U-937 permeabilized cells, has been shown to be sensitive to
the concentrations of 3-AB normally used to prevent apopto-
sis. At 1 mM 3-AB inhibition of PKC activity was approx-
imately 60% when phorbol myrisate acetate was used to acti-
vate the kinase. H2O2 was also able to stimulate PKC in U-
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937 cells, although to a lesser extent relative to the phorbol
ester. The inhibition by 3-AB on H2O2-stimulated PKC activ-
ity was, however, of the same order of magnitude (i.e. 60%).
The following conclusion can be drawn from these experi-
ments. 3-AB is not a speci¢c inhibitor of PARP, being, at the
same concentrations, also able to substantially inhibit PKC.
Such a lack of speci¢city should be kept in mind in interpret-
ing results obtained with this tool, especially regarding apop-
tosis, since programmed cell death is strongly a¡ected by
PKC.
A further question has been answered with the experiments
of Fig. 2. In the experiment carried out at a cellular level, after
3-AB addition, a dose-dependent inhibition of protein kinase
C activation has been seen. Using a recombinant PKCK in
vitro no e¡ect of the inhibitor was seen, even at concentra-
tions ten-fold higher than those employed at a cellular level.
This result suggests that the inhibition of PKC, seen at a
cellular level, should not be due to a direct protein kinase
C/3-AB interaction. Rather an indirect mechanism may be
postulated, involving changes in the permissive phosphoryla-
tion state of the enzyme. The time course of 3-AB incubation
with PKC was too short to assume that the compound pro-
duced a change in protein synthesis. An analogy can be drawn
with the mechanism of K-tocopherol inhibition of protein kin-
ase CK that has been shown to involve dephosphorylation of
the enzyme, possibly by a protein phosphatase 2A [22,23]. The
molecular mechanism of PKC inhibition by 3-AB is currently
under investigation.
The results presented in this study show that in a cellular
system 3-AB inhibits protein kinase C activity in a dose-de-
pendent manner. The protein kinase C inhibition appears to
occur via an indirect mechanism since no inhibition by 3-AB
takes place with the isolated recombinant enzyme.
Several inhibitors of PARP have been used as tools to show
a role of this enzyme in cell death. 3-AB in particular is the
most frequently used, since it has been supposed to be non-
toxic and highly speci¢c. The data reported here show instead
that another enzyme, protein kinase C, is equally inhibited.
Since protein kinase C is also involved in apoptosis, caution
should be taken in interpreting data on programmed cell
death based on the use of 3-AB.
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Fig. 1. Protein kinase C activity in permeabilized U-937 cells. U-937
cells have been treated with or without 1 mM 3-AB for 2 h. During
the last hour PMA (100 nM) or H2O2 (1 mM) were added, as indi-
cated in the picture. The vertical bars represent the þ S.D. of the
average of four di¡erent experiments.
Fig. 2. E¡ect of 3-AB on protein kinase C activity in permeabilized
U-937 cells and with the isolated enzyme. For the measurement in
permeabilized cells (left panel), conditions were as described in Fig.
1, and PMA was used as PKC activator. 3-AB concentrations were
varied according to the ¢gure. On the right panel the e¡ect of 3-AB
on puri¢ed, recombinant PKC is shown. Conditions are described
in Section 2. The value of the untreated protein kinase C activity
was of 4.8 arbitrary units, i.e. not signi¢cantly di¡erent from those
of treated samples. The addition of 3-AB after activation of the en-
zyme gave results identical to those shown here. The vertical bars
represent the þ S.D. of the average of four di¡erent experiments.
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